| 000 | 01758 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513230033.0 | ||
| 264 | 0 | _c20010308 | |
| 008 | 200103s 0 0 eng d | ||
| 022 | _a0169-328X | ||
| 024 | 7 |
_a10.1016/s0169-328x(00)00234-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCamandola, S | |
| 245 | 0 | 0 |
_aThe lipid peroxidation product 4-hydroxy-2,3-nonenal inhibits constitutive and inducible activity of nuclear factor kappa B in neurons. _h[electronic resource] |
| 260 |
_bBrain research. Molecular brain research _cDec 2000 |
||
| 300 |
_a53-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAldehydes _xpharmacology |
| 650 | 0 | 4 |
_aAlzheimer Disease _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCerebral Cortex _xcytology |
| 650 | 0 | 4 |
_aCycloheximide _xpharmacology |
| 650 | 0 | 4 |
_aCysteine Proteinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aLipid Peroxidation _xphysiology |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNerve Degeneration _xmetabolism |
| 650 | 0 | 4 |
_aNeurons _xcytology |
| 650 | 0 | 4 |
_aOkadaic Acid _xpharmacology |
| 650 | 0 | 4 |
_aProtein Synthesis Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aStroke _xmetabolism |
| 650 | 0 | 4 |
_aTranscription Factor AP-1 _xmetabolism |
| 650 | 0 | 4 |
_aVanadates _xpharmacology |
| 700 | 1 | _aPoli, G | |
| 700 | 1 | _aMattson, M P | |
| 773 | 0 |
_tBrain research. Molecular brain research _gvol. 85 _gno. 1-2 _gp. 53-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0169-328x(00)00234-5 _zAvailable from publisher's website |
| 999 |
_c11086091 _d11086091 |
||